SG10201408485SA - Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents - Google Patents

Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents

Info

Publication number
SG10201408485SA
SG10201408485SA SG10201408485SA SG10201408485SA SG10201408485SA SG 10201408485S A SG10201408485S A SG 10201408485SA SG 10201408485S A SG10201408485S A SG 10201408485SA SG 10201408485S A SG10201408485S A SG 10201408485SA SG 10201408485S A SG10201408485S A SG 10201408485SA
Authority
SG
Singapore
Prior art keywords
artemisinin
chemotherapeutic agents
based drugs
anticancer combination
combinations
Prior art date
Application number
SG10201408485SA
Other languages
English (en)
Inventor
Claudio Pisano
Loredana Vesci
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of SG10201408485SA publication Critical patent/SG10201408485SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SG10201408485SA 2009-12-23 2010-12-06 Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents SG10201408485SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09180666 2009-12-23

Publications (1)

Publication Number Publication Date
SG10201408485SA true SG10201408485SA (en) 2015-01-29

Family

ID=41647059

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201408485SA SG10201408485SA (en) 2009-12-23 2010-12-06 Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents

Country Status (20)

Country Link
US (1) US9023861B2 (es)
EP (1) EP2515898A1 (es)
JP (1) JP2013515690A (es)
KR (1) KR20120096053A (es)
CN (1) CN102665711A (es)
AR (1) AR079654A1 (es)
AU (1) AU2010335422A1 (es)
BR (1) BR112012015606A2 (es)
CA (1) CA2780591A1 (es)
EA (1) EA201200934A1 (es)
IL (1) IL220561A0 (es)
IN (1) IN2012DN03914A (es)
MX (1) MX2012006738A (es)
MY (1) MY157475A (es)
NZ (1) NZ599878A (es)
SG (1) SG10201408485SA (es)
TW (1) TWI482621B (es)
UA (1) UA107691C2 (es)
WO (1) WO2011076547A1 (es)
ZA (1) ZA201205360B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314473B2 (en) 2011-02-03 2016-04-19 Pop Test Oncology Limited Liability Company System and method for diagnosis and treatment
US9801851B2 (en) * 2012-05-23 2017-10-31 St. Jude Children's Research Hospital Methods and compositions for the treatment of BCR-ABL positive lymphoblastic leukemias
US20170049815A1 (en) * 2014-05-02 2017-02-23 Emory University Selective Chemotherapy Treatments and Diagnostic Methods Related Thereto
US9918972B2 (en) * 2014-12-23 2018-03-20 The University Of Maryland, Baltimore Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents
CN105963262B (zh) * 2016-06-06 2018-11-30 北京林业大学 一种两亲性果胶-双氢青蒿素纳米粒子的制备方法
CN110051849A (zh) * 2016-08-26 2019-07-26 宁国市厚普生物科技有限公司 一种复合物在制备用于治疗乳腺癌的药物中的应用
CN109453156A (zh) * 2018-11-22 2019-03-12 中国中医科学院中药研究所 一种抗肿瘤组合物及其应用、抗肿瘤药物
CN114053271B (zh) * 2020-07-30 2024-05-07 江苏天士力帝益药业有限公司 一种含有tsl-1502m的药物组合物及其应用
CN114053276B (zh) * 2020-07-30 2024-05-07 江苏天士力帝益药业有限公司 一种parp抑制剂tsl-1502中间体tsl-1502m的用途
CN114010643A (zh) * 2021-11-23 2022-02-08 温州医科大学 双氢青蒿素在抗肿瘤药物的制备中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578637A (en) 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
PT1044977E (pt) 1999-03-09 2002-09-30 Sigma Tau Ind Farmaceuti Derivados de camptotecina com actividade antitumoral
KR100390332B1 (ko) 2000-08-02 2003-07-07 유원민 항말라리아제와 항암제의 병용투여에 의한 항암제 복합 조성물
ATE485039T1 (de) 2003-02-12 2010-11-15 Univ Georgetown Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
EP1658844A1 (en) 2004-10-19 2006-05-24 Gerold Schuler Use of artemisinin derivatives in the manufacture of a medicament for the treatment of melanoma
TWI375673B (en) 2005-04-11 2012-11-01 Abbott Lab 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
US8143284B2 (en) * 2006-10-05 2012-03-27 Abbott Laboratories Poly(ADP-ribose)polymerase inhibitors
PT2086525E (pt) 2006-11-20 2010-12-09 Cephalon Inc Método de radiossensibilização de tumores utilizando um radiossensibilizador
CN101125140B (zh) * 2007-09-18 2011-04-13 浙江大学 二氢青蒿素在制备增强化疗药物抗肿瘤疗效的药物中的应用
WO2009114459A2 (en) * 2008-03-10 2009-09-17 The Trustees Of The University Of Pennsylvania Anti-neoplastic combination therapeutic regimen involving co-disruption of parp pathway and mre11/rad50/nbs1 complex and compositons useful therein
CN101380325A (zh) * 2008-10-23 2009-03-11 上海交通大学 青蒿素衍生物与长春瑞滨的组合物及其应用
CN101428034B (zh) * 2008-12-12 2012-02-08 广州市允中投资发展有限公司 具有增效减毒特点的抗肿瘤组合药物
CN101856352A (zh) * 2009-04-10 2010-10-13 中国科学院上海生命科学研究院 青蒿素及其衍生物对化疗剂的协同作用

Also Published As

Publication number Publication date
NZ599878A (en) 2014-06-27
ZA201205360B (en) 2013-05-29
KR20120096053A (ko) 2012-08-29
JP2013515690A (ja) 2013-05-09
CN102665711A (zh) 2012-09-12
EA201200934A1 (ru) 2012-12-28
EP2515898A1 (en) 2012-10-31
US9023861B2 (en) 2015-05-05
UA107691C2 (ru) 2015-02-10
AR079654A1 (es) 2012-02-08
CA2780591A1 (en) 2011-06-30
TW201138764A (en) 2011-11-16
TWI482621B (zh) 2015-05-01
MX2012006738A (es) 2012-07-03
US20120258181A1 (en) 2012-10-11
IN2012DN03914A (es) 2015-09-04
BR112012015606A2 (pt) 2018-05-29
WO2011076547A1 (en) 2011-06-30
MY157475A (en) 2016-06-15
AU2010335422A1 (en) 2012-06-07
IL220561A0 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
SG10201408485SA (en) Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents
HRP20181217T1 (hr) Nanočestica koja kao antikancerogeno sredstvo sadrži rapamicin i albumin
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
IL193467A0 (en) Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
IL213920A0 (en) 3,3'-spiroindolinone derivatives as anticancer agents
HK1140219A1 (en) Water-soluble iron-carbohydrate derivative complexes, preparation thereof and medicaments comprising them
IL195279A (en) Annals of 1-phenyl-5- [2-hydroxy-4- (hydroxy / methoxy)] phenyl-pyrazole, a process for their preparation and medications containing them
IL196653A (en) Kempthetine derivatives, preparations containing them, their uses for drug preparation and processes for their preparation
IL197212A0 (en) Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
IL213570A (en) History 8 - Alkoxy - s - Triazolo [5,1 - a] pyridine and pharmaceutical preparations containing them
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
IL217500A0 (en) Tetrazole derivatives, their preparartion and pharmaceutical compositions containing them
EP2096924A4 (en) NEW HYDROPHIL DERIVATIVES OF 2-ARYL-4-CHINOLONES AS ANTICROBIAL AGENTS
IL210975A (en) Annapomapungin History, Pharmaceuticals Containing Them and Their Use in Preparing Medicines to Treat Fungal Infections
IL199078A (en) Converted quinoline derivatives, pharmaceutical preparations, combinations and products containing them, their uses and processes for their preparation
EP2348019A4 (en) 1,2-DIAZETTIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME
WO2008064060A3 (en) Dicarbonyl derivatives and methods of use
EP1994003A4 (en) PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEY
WO2008045294A3 (en) Boosting immunity
TWI368525B (en) Nanoparticles as paracellular drug delivery system
DE602007009396D1 (en) Camptothecinderivate mit antitumorwirkung